R&D

HIV Vaccine on the Horizon: Researchers Design HIV Immunogens

HIV Vaccine on the Horizon: Researchers Design HIV Immunogens

Written by on July 29, 2014 in Featured on App, R&D, Therapeutic Vaccines with 0 Comments

Researchers from Duke University have Discovered a Way to Elicit an Immune Response in Individuals Infected With HIV-1, the Most Common Form of the Virus The director of the Duke Center for HIV/AIDS Vaccine Immunology and Duke Human Vaccine Institute, Dr.Barton Haynes, recently published his teams findings in the reputable scientific journal ‘Cell.’ In a […]

Continue Reading

Top 3 Sparks of Interest for Leading Vaccine Academics

Top 3 Sparks of Interest for Leading Vaccine Academics

Written by on July 24, 2014 in Featured on App, R&D with 0 Comments

Recently we undertook the research for the 15th annual World Vaccine Congress. As part of that research, we spoke to leading vaccine academics from the likes of University of Oxford and Erasmus MC to find out what they thought were the most interesting trends in industry at the moment. These were the top 3: 1. […]

Continue Reading

Therapeutic

Researchers Create Vaccine for Dust-Mite Allergies

Researchers Create Vaccine for Dust-Mite Allergies

Written by on July 23, 2014 in Featured on App, R&D, Therapeutic Vaccines with 0 Comments

If you’re allergic to dust mites (and chances are you are) help may be on the way Researchers at the University of Iowa have developed a vaccine that can combat dust-mite allergies by changing the body’s immune response. In animal tests, the vaccine lowered lung inflammation by 83 percent, according to the paper published in […]

Continue Reading

New Research Finds a Way to Predict Which HIV Patients Will Respond Better to Future Therapeutic Vaccine

New Research Finds a Way to Predict Which HIV Patients Will Respond Better to Future Therapeutic Vaccine

Written by on July 21, 2014 in Featured on App, R&D, Therapeutic Vaccines with 0 Comments

A new study suggests that HIV patients with a higher level of a particular biomarker may respond more favourably to an experimental immune activating vaccine Researchers at St George’s, University of London and Norwegian vaccine company Bionor believe the findings might lead to a customised vaccine for certain patients, which might permit them to come off […]

Continue Reading

Prophylactic

HPV Vaccination Coverage Remains Unacceptably Low in the US

HPV Vaccination Coverage Remains Unacceptably Low in the US

Written by on July 29, 2014 in Featured on App, News, Prophylactic Vaccines with 0 Comments

A New Report From the US Centers for Disease Control and Prevention Has Stated That HPV Vaccine Coverage in the US is Too Low Human Papillomavirus (HPV), the leading cause of cervical cancer, is the most common sexually transmitted disease in the US. The virus comes in over 150 forms, and approximately 4 of these […]

Continue Reading

Has the Time Come to Test Experimental Ebola Vaccines?

Has the Time Come to Test Experimental Ebola Vaccines?

Written by on July 28, 2014 in Featured on App, News, Prophylactic Vaccines with 0 Comments

The Ebola Virus is Spreading Across West Africa in The Largest Outbreak To Date Mortality rates are currently at 60%, where normally up to 90% of affected people die. Unfortunately, there are no cures or vaccines for the disease, despite its emergence in 1976. In March of this year, cases of Ebola were reported for […]

Continue Reading

Flu

New York City Stands up To Anti-Vaccine Parents

New York City Stands up To Anti-Vaccine Parents

Written by on June 26, 2014 in Flu, News, Regulation and Policy with 0 Comments

New York City judge rules that religious grounds are not enough to put your child in harm’s way The fight against unnecessary vaccine exemptions reached a milestone last week when a New York City judge ruled against three families who claimed that their right to free exercise of religion was violated when their un-vaccinated children […]

Continue Reading

DIY Spanish Flu: Critics up in arms as scientists recreate deadly 1918 virus

DIY Spanish Flu: Critics up in arms as scientists recreate deadly 1918 virus

Written by on June 13, 2014 in Flu, News with 1 Comment

Using a technique known as reverse genetics, a team from University of Wisconsin-Madison were able to build a virus 93% similar to the 1918 Spanish flu by utilizing 8 genes found in recent avian flu strains. The result was a flu virus more pathogenic than current avian flu strains, but less so than the Spanish […]

Continue Reading

Regulation & Policy

Lost Small Pox Vials and Anthrax Mishaps

Lost Small Pox Vials and Anthrax Mishaps

Written by on July 15, 2014 in News, Regulation and Policy, Supply Chain with 0 Comments

  Will small pox and anthrax biosafety concerns undermine vital research? Last week the US Centres for Disease Control and Prevention announced that 6 small pox vials had been discovered on the 1st of July during the clearing out of an old laboratory at the Nationality Institute of Health’s (NIH) Bethesda campus, Maryland. The six […]

Continue Reading

Vaccines & Adverse Events: A comprehensive guide

Vaccines & Adverse Events: A comprehensive guide

Written by on July 2, 2014 in Featured on App, News, Regulation and Policy with 0 Comments

Yet another report shows that vaccines are safe A meta-analysis, published today in Pediatrics, looked at 67 papers (reduced from 20,478 titles) on vaccine safety. The paper concluded that there is evidence to link some vaccines with serious adverse events, but that these adverse events are so extremely rare that, when weighed against the protective benefits […]

Continue Reading

Emerging Markets

World’s first Malaria Vaccine Submitted for Approval to EMA

World’s first Malaria Vaccine Submitted for Approval to EMA

Written by on July 24, 2014 in Emerging Markets with 0 Comments

GlaxoSmithKline submits the first malaria vaccine for approval by the European Medicines Agency and the World Health Organization The vaccine, named RTS,S, targets Plasmodium falciparum parasite. This parasite is most commonly found in sub-Saharan, where 90% of malaria related deaths occur. Children under 5 account for 77% of the deaths. The vaccine uses the AS01 adjuvant […]

Continue Reading

The Animal Medicine and Veterinary Vaccines Sector – a $22 billion market

The Animal Medicine and Veterinary Vaccines Sector – a $22 billion market

Written by on July 17, 2014 in Emerging Markets, News, Veterinary Vaccines with 0 Comments

  As highlighted by Zoetis , the largest global animal healthcare company and latest exhibitor partner to the Vaccine Congress Washington 2015, the animal medicines and veterinary vaccines sector is estimated to represent a global market of $22 billion within the approximate $92 – 102 billion animal health industry.   Additionally between 2011 and 2016, the […]

Continue Reading

Supply Chain

Ensuring Critical Vaccine Supply: Raw Materials Perspective

Ensuring Critical Vaccine Supply: Raw Materials Perspective

Written by on June 25, 2014 in Features & Downloads, Supply Chain with 0 Comments

Frank Appel, Senior Manager, Europe Vaccines Segments, Process Solutions, Merck Millipore joined us last year at the World Vaccine Congress Europe to present on ‘Ensuring Critical Vaccine Supply: Raw Materials Perspective.’ Download this presentation now to find out more about: Ensuring Safety: A real challenge & business risk The Reality of Upstream Contamination BioSafety Strategy […]

Continue Reading

4 Revolutionary Ways to Predict Pandemics

4 Revolutionary Ways to Predict Pandemics

Increasingly we are looking towards big data and analytics to help us with everything from how best to utilise your manufacturing capacity, to analysing potential candidates for emerging infectious diseases. But big data has been around for a number of years in the field of pandemic prediction. Here we have 4 of revolutionary methods that […]

Continue Reading

Strategy and Partnering

How to choose your perfect CRO partner

How to choose your perfect CRO partner

Deciding upon the correct CRO is a crucial element of each vaccine’s development for the likes of biotech’s and pharma, concerned with outsourcing their research. This eBook answers the all-important question of how to choose your perfect CRO partner by providing a checklist of the top 10 criteria that sponsors use for selecting CROs. Thereby […]

Continue Reading

Pfizer Vaccines: Behind the giant

Pfizer Vaccines: Behind the giant

Pfizer Vaccines business is one the biggest in the world, and plays host to the best selling vaccine in the world: Prevnar 13. And despite a very small product list, Prevnar’s dominance over the pneumococcal market allows them to bring in over $4 billion a year through Prevnar 13 alone. Pfizer Vaccines are also one of […]

Continue Reading

Other Recent Posts

Your ticket to biopharma networking… Shhh, it’s a secret!

Vaccine Nation invites all UK-based life science professionals to our monthly industry meet-ups! Running on the first Tuesday of every month, we are hosting these informal industry networking evenings at an assortment of secret London locations.  They are for all local life science professionals looking to build their networks and meet with like-minded people over […]

Continue Reading

Wild Horses Benefit from Contraceptive Vaccine

-Boston-based animal protection organization, FOUR PAWS International, sends tranquilizer darts to help horses in the Danube Delta. July 28th, 2014 Animal protection organization, FOUR PAWS International, is helping to preserve the 500 wild horses currently living in the Letea Forest in Romania. The Letea Forest, which is situated in the northeastern part of the Danube […]

Continue Reading

Batu Biologics Strategy for FDA Approval of Lung Cancer Immunotherapy Featured in San Diego Business Journal

July 27th, 2014 Batu Biologics announced today that it’s President and CEO, Samuel C. Wagner, was featured in the weekly business publication, the San Diego Business Journal. The article, which was published in the July 21st edition, discussed the company’s strategy in developing its immunotherapeutic lung cancer vaccine, ValloVax, for which FDA Investigational New Drug (IND) […]

Continue Reading

Top
Geolocation